The government recently made it mandatory for knee implant manufacturers and importers to maintain production and supply of knee implants by invoking an emergency clause under the drug price control law.
The department of pharmaceuticals (DoP) under the ministry of chemicals and fertilizers invoked powers under the Drugs (Prices Control) Order, 2013, to mandate firms to continue the sale of knee implants without interruption, following the recent price cap on knee implants. DoP, in its order posted on its website on Tuesday, directed firms to submit a weekly report on “distribution” and “production” of knee implant systems.
